Abstract : Myelodysplastic syndromes are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by persistent peripheral cytopenia with morphological and functional abnormalities of hematopoietic cells. Mast cells in ltrate into or around tumor tissues and play a role in remodeling of the stromal microenvironment, contributing to tumor progression. Increased mast cell numbers are associated with brosis, angiogenesis and a poor prognosis in human carcinomas. The aim of this study was to determine whether mast cell infiltration contributes to myelofibrosis or angiogenesis in myelodysplastic syndromes. We evaluated the correlation between mast cell density and the extent of myelofibrosis and angiogenesis in myelodysplastic syndromes. Fifty bone marrow biopsies taken from patients with a diagnosis of myelodysplastic syndromes were examined. Grading of myelo brosis was evaluated by silver impregnation staining. Mast cell density and microvessel density were evaluated by immunohistochemistry. Human mast cells have been divided into two phenotypes. We designated a tryptase-positive mast cell as MC T and a chymase-positive mast cell as MC TC . Microvessels were identied by CD34-positive endothelial cells. Microvessel density and the extent of myelo brosis were signi cantly greater in patients with high MC T and MC TC density compared to those with low MC density. Based on this, we suggest that the presence of high mast cell numbers is associated with myelo brosis and angiogenesis in myelodysplastic syndromes.
Elevated MC numbers in human carcinomas, including hepatocellular carcinoma, cholangiocarcinoma 4 , oral squamous cell carcinoma 5 , and pulmonary adenocarcinoma 6 , are associated with brosis, angiogenesis and a poor prognosis. MCs may also be associated with brosis and angiogenesis in lymphomas. Molin and colleagues found a higher number of MCs in nodular sclerosis classical Hodgkin lymphoma than in other types of Hodgkin lymphoma, and patients with higher MC in ltration have reduced relapse-free survival 7 . In B-cell nonHodgkin s lymphoma, the MC density is correlated with microvessel density MVD , and both densities increase in parallel with increasing grade of malignancy 8 . Fukushima and colleagues reported that MCs are associated with brosis in diffuse large B-cell lymphoma 9 .
An increase in the MC count is also seen in MDS 10, 11 . There are some reports that MC numbers often increase in MDS with myelo brosis 12 and the extent of angiogenesis correlates with the number of MCs in MDS 13 . In this study, we evaluated the correlation of MC T and MC TC density with the extent of myelo brosis and angiogenesis in MDS, to investigate whether MC in ltration contributes to myelo brosis and angiogenesis in MDS and to clarify the alteration of BM microenvironment in MDS.
Methods

Patients
We examined paraf n-embedded trephine BM biopsies from 72 patients with a diagnosis 1 ; RARS, n 1 ; refractory cytopenia with multilineage dysplasia RCMD , n 14 ; RAEB-1, n 14 ; RAEB-2, n 6 ; MDS associated with isolated deletion of 5q, n 1 ; and AML with myelodysplasia-related changes, n 10. Although chronic myelomonocytic leukemia has recently been removed from the de nition of MDS, 3 cases were included in the study to examine possible differences between chronic myelomonocytic leukemia and MDS subtypes.
As controls, BM biopsies from 5 patients with no evidence of lymphoma cell in ltration, performed for diagnostic purposes as a part of staging procedures for classical Hodgkin lymphoma n 1 and non-Hodgkin lymphoma n 4 , were also evaluated.
Bone marrow analysis
The specimens were xed in 10 buffered formalin, decalci ed in 10 buffered EDTA pH 7.2 , and embedded in paraf n. The paraf n-embedded tissue sections were stained using hematoxylin and eosin HE , Giemsa stain, naphthol-ASD-chloroacetate, and silver impregnation for histological investigation. Semiquantitative evaluation of BM cellularity was performed with a scoring system based on cell numbers in normal BM : 0, no increase in comparison with the normal state ; 1 / 1, mild to moderate increase / decrease ; 2 / 2, marked increase / decrease 16 . Immunohistochemical staining was performed on the same tissue sections. Examination of the biopsies was carried out independently by two investigators unaware of the patients diagnosis and clinical data. Patient samples were taken at the time of initial diagnosis. In the cases that progressed to AML n 14 , we examined the nine BM biopsies at the time of overt leukemia development if they were available.
Myelo brosis grading
Grading of myelofibrosis accumulation of reticulin and collagen fibers followed the semiquantitative scoring system 17 : MF-0, scattered linear reticulin with no intersections cross-overs corresponding to normal BM ; MF-1, loose network of reticulin with many intersections, especially in perivascular areas ; MF-2, diffuse and dense increase in reticulin with extensive intersections, occasionally with only focal bundles of collagen and / or focal osteosclerosis ; and MF-3, diffuse and dense increase in reticulin with extensive intersections with coarse bundles of collagen, often associated with signi cant osteosclerosis.
Immunohistochemistry
Formalin-xed, paraf n-embedded specimens of BM biopsies were examined by immunohistochemical staining procedures. We used monoclonal antibodies against tryptase 10D11, Novocastra, Newcastle-upon-Tyne, UK ; diluted 1 : 150 to detect MC T , chymase CC1, MBL, Nagoya, Japan ; diluted 1 : 100 to detect MC TC 18 , and CD34 NU-4A1, Nichirei, Tokyo, Japan ; diluted 1 : 50 to detect blood vessels identi ed by CD34-positive endothelial cells.
Tissue sections were deparaf nized with xylene, rehydrated in a series of graded alcohols, and then immersed in 3 H 2 O 2 to quench the endogenous peroxidase activity. For CD34 staining, sections were then subjected to microwave antigen retrieval in citric acid buffer at pH 7.0 for 30 min at 98 . After incubation with primary monoclonal antibodies for 90 min at room temperature, immunohistochemical staining was performed using an Envision Kit DakoCytomation, Glostrup, Denmark . Diaminobenzidine was used for color development, and hematoxylin was used for counterstaining.
Mast cell counts
The number of tryptase-positive and chymase-positive MCs in the specimens were quantied using a computerized morphometry system WinROOF ver. 5.01, Mitani Corp., Tokyo, Japan . MC T and MC TC densities were expressed as the absolute number of tryptasepositive or chymase-positive MCs per 1 mm 2 of hematopoietic area in BM biopsies.
Quanti cation of microvessel density
CD34 is a useful antigen for assessing intratumor angiogenesis in solid tumors and meets the high quality requirements for BM angiogenesis research. Blood vessels were de ned by CD34-positive endothelial cells forming a structure with a clearly discernible lumen. This de nition is important to discriminate blood vessels from CD34-positive myeloid progenitors. Myeloid stem cells are also CD34-positive, but these cells can be excluded by their morphology, even if highly abundant 19 . Slides were rst scanned at 100 magni cation and 3 areas with abundant microvessels were chosen and de ned as hot spots . The number of microvessels in each of these hot spots was then determined at 400 magni cation. The nal MVD microvessels per eld at 400 magni cation was determined by taking the average of 3 separate visual counts. Large vessels and vessels in the periosteum or bone were not counted.
Statistical analysis
All statistical analyses were performed using StatView software ver. or MVD before and after transformation to MDS-OL.
Discussion
The BM microenvironment is regulated by stromal cells, including endothelial cells and macrophage-lineage cells. The stromal microenvironment is composed of vessels, broblasts and several kinds of inflammatory cells, and it influences tumor growth and progression.
MCs in ltrate into or around tumor tissues and play a role in remodeling of the stromal microenvironment, which leads to tumor progression. Human MCs are conventionally divided into two types depending on the expression of different proteases in their gran- In our study, however, the only signi cant difference between MDS cases with and without myelo brosis was that the BM smear nucleated cell count was lower in high-brosis cases than in low-brosis cases. The extent of the myelo brosis can be such that BM aspiration results in either dry taps or extremely scanty and non-representative aspirates, which may produce lower BM smear nucleated cell counts in MDS with myelo brosis. A previous study linked myelofibrosis to a poor prognosis in terms of life expectancy and time to leukemic transformation 21 , however Pagliuca and colleagues found relatively long survival in a series of 10 MDS patients with myelo brosis 22 , and Rios and colleagues did not nd a signi cant correlation between myelo brosis and reduced survival 23 . Therefore, the relationship between the occurrence of myelo brosis in MDS and survival is still controversial.
MC density is also correlated with the extent of pathological angiogenesis, such as that in chronic in ammatory diseases and tumors. In our study, both the MC T and MC TC densities were higher in the high MVD group than in the low MVD group. MCs contain many angiogenic factors, such as heparin and histamine, and a variety of cytokines and chemokines, such as transforming growth factor-, tumor necrosis factor-, IL-8, basic fibroblast growth factor also known as fibroblast growth factor-2 and vascular endothelial growth factor 13 . Tryptase acts as a mitogen for broblasts, smooth muscle cells and epithelial cells, so tryptase released from MCs also plays an important role in neovascularization.
Abnormal angiogenesis has been implicated in the pathogenesis of MDS, and increased MVD in the BM of patients with MDS has also been described 24 . We found no signi cant correlation between MVD and clinico-histological parameters. Some studies have reported increased MVD in hypercellular MDS than normocellular or hypocellular cases 25, 26 , however other studies found no significant correlation between MVD and BM cellularity, PB counts, or percentage of BM myeloblasts 19, 24 . Similarly, most studies have failed to show a significant correlation between MVD and prognostic factors, including overall survival, progression-free survival and IPSS score. Ribatti and colleagues, however, showed that angiogenesis in MDS was correlated with total metachromatic and tryptase-positive MC counts and that microvessels and MC counts increased together with MDS progression 13 .
In our study, there was no signi cant correlation between MVD and MDS progression, however MC TC densities were higher in patients with high MVD, suggesting that MC chymase may play an important role in angiogenesis in MDS. 10 . In our study, there was no signi cant difference in MC density between MDS cases and controls, however our control samples were BM biopsies from patients with malignant lymphoma, which may be somewhat biased, even without in ltration of lymphoma cells.
Stem cell factor, which is produced mainly by stromal cells, is the principal growth factor for human MCs 28 , while MCs also induce stem cell factor. In MDS, levels of stem cell factor may increase as the period of ineffective hematopoiesis and cytopenia becomes longer. Therefore, MCs may also increase with the period of cytopenia. MCs induce various biochemical mediators to promote brosis, while stem cell factor is produced by mainly broblasts. Consequently, whether the increase of MCs contributes to the development of brosis or results from brosis is still a matter of discussion.
Recently, Chiu and colleagues suggested that the fibrogenetic mechanism in systemic mastocytosis is most likely different from that of other BM neoplasms which are also associated with myelo brosis 29 . Systemic mastocytosis is a stem cell disorder characterized by a pathological accumulation of clonal MCs in one or more organ system. The MC aggregates are accompanied by brosis. In their study, there was no signi cant expression of type IV collagen or laminin in BM of systemic mastocytosis, compared with primary myelo brosis or metastatic malignancy. Normal BM MCs are reported to be round to oval in shape 30 .
Horny and colleagues reported round to oval shape MCs in many cases of MDS, while in the cases of mastocytosis, the MC shape showed variability ; spindle shaped cells were the predominant cell type in most cases 20 . These differences in MC morphology may affect the different mechanisms of myelo brosis in MDS and systemic mastocytosis. In our study, both round to oval MCs and spindle MCs were detected, but there were more round to oval MCs than spindle MCs. From this, we infer that the increase in MC numbers in MDS is reactive, and not due to clonal proliferation.
Based on the results of this study, we suggest that MC T and MC TC densities are correlated with the extent of myelo brosis and angiogenesis in MDS. Evaluation of possible correlations between the outcome of patients with MDS and MC density and the extent of myelo brosis or angiogenesis will require a study with a larger series of cases.
